Podcast: World Parkinson’s Day – an idea that blossomed and bloomed

09 April 2025 Anthony Zahra
Podcasts

As the Parkinson’s Life podcast marks World Parkinson’s Day 2025, the latest episode speaks to Lizzie Graham, co-founder of Parkinson’s Europe and former Secretary General.

Lizzie was one of the key driving forces behind the creation of Parkinson’s Europe, then called the European Parkinson’s Disease Association (EPDA), back in the early 1990s.

She was also instrumental in launching the very first World Parkinson’s Day in 1997, recalling how they gained support from the likes of Princess Diana, Muhammad Ali, and Pope John Paul II.

Lizzie remembers the poignant moment that she says has spurred her on to continue working in the field of Parkinson’s, recalling: “I realised then what a horrible condition it is.” Lizzie’s son, Parkinson’s Europe’s Operations Director, Dominic Graham, also appears on the episode, sharing how proud he is of his mum’s “selfless” work.

As well as raising awareness about Parkinson’s, the first World Parkinson’s Day saw the launch of the Parkinson’s Europe Charter, a document which sets out the rights of people with Parkinson’s.

Lizzie says those original five principles have formed the basis for all the work Parkinson’s Europe has done since.

Sharing plans for World Parkinson’s Day

We also meet Jessie Duncan, European Outreach and Engagement Manager at Parkinson’s Europe, who tells us what’s happening across Europe to mark World Parkinson’s Day.

We would love to hear about your plans for World Parkinson’s Day. Parkinson’s Europe has launched an interactive map, highlighting the many events that are taking place on and around April 11th. To get your event added, let us know about it by emailing: [email protected].

And we would love to hear your Parkinson’s stories, too. Get in touch via social media to share your story, or email [email protected]. As Parkinson’s Life podcast host Amelia puts it: “World Parkinson’s Day is for everyone, not just people with Parkinson’s.”

Meet your hosts:
Amelia Hursey is Strategic Director at Parkinson’s Europe. She has a master’s in cognitive neuropsychology and has been involved in the neurodegenerative research world for 15 years.

Anthony Zahra is a broadcaster and journalist with more than 20 years’ experience in radio, digital and podcasting.

Listen to the full episode on Spotify, or on your podcast provider of choice. If you like what you’ve heard, please rate and review – it helps make sure others can find us.

Explore more of our Parkinson’s Life podcasts, with episodes covering Parkinson’s research, how to deal with “off” periods, sex and intimacy in Parkinson’s, and women and Parkinson’s. Never miss an episode by subscribing to the Parkinson’s Life podcast on Spotify, Apple Music, or your streaming service of choice.

Parkinson’s Europe is sharing this article for information purposes only; it does not represent Parkinson’s Europe’s views and is not an endorsement by Parkinson’s Europe of any particular treatments, therapies or products.

Europe and the world face challenge as neurological diseases rise, says EAN President

To mark Brain Awareness Week, Parkinson’s Europe spoke to the President of the European Academy of Neurology Elena Moro about its Brain Health Mission and advocacy work
12 March 2025 Verity Willcocks
Insights
Elena Moro

Europe and the rest of the world are facing a “pandemic” of neurological diseases, says Elena Moro, the President of the European Academy of Neurology (EAN), with the economic burden of neurological diseases in Europe alone estimated at €1,7 trillion in 2020.

This figure – covering the costs of medical care, rehabilitation, lost productivity, and caregiving for individuals with neurological diseases including Parkinson’s – is more than the combined costs of cardiovascular disease, cancer and diabetes, according to the EAN.

“That is a massive cost that we cannot afford because the same neurodegenerative diseases are increasing, and the number of neurologists is decreasing,” says Moro. “How can you treat or manage all these people living with their neurological disorder if you don’t start thinking about prevention or managing the diseases a little better?”

Keen to help tackle this immense challenge, the EAN decided to play a more proactive role in improving brain health in Europe.

Moro explains that the idea came to fruition around four years ago, when Claudio Bassetti was EAN president. “He wrote a paper in which he stressed the need for a holistic approach to the brain,” she says.

“We decided to start in a very structured way, with people dedicated to developing a specific plan, which has been published and has five pillars,” says Moro.

The EAN’s Brain Health Mission plan

The EAN’s strategy for improving brain health was published in the European Journal of Neurology in January this year, in an article called “A roadmap toward promoting and improving brain health in Europe and closing the awareness and funding gap”. Its five pillars were listed as: “advancing a global brain health approach; supporting policymaking; fostering research; promoting education; and raising awareness of prevention and treatment”.

Of these, Moro highlights the need for more brain research as particularly important: “There’s a lot of areas that we don’t understand very well. We need to pin down all these determinants of health, and especially brain health, and how to be more effective in dealing with that.

“If we invest a little more in research, in understanding these basic areas, we will take the advantage in preventing and in making neurodegenerative disorders, including Parkinson’s disease, less disabling.”

Brain health matters

“What is written in the roadmap is the framework, right now we are starting to fill the framework with initiatives that we think are the preliminary important action to build further on it,” says Moro. “We have established quite practical initiatives, and we are building on this.”

One of the EAN’s activities, Moro explains, is to work very closely with Europe’s 48 national neurological societies and support them in persuading their respective governments of the urgent need to develop and implement a brain health plan for every European country.

“In Europe, only three countries have a brain health plan. One is Norway. One is Italy, and the other is Switzerland. So, you can imagine that there’s a lot of work to do,” she says.

Moro also adds that each country will need a different plan according to their specific characteristics and population.

“It is different if you live in Norway, or if you live in Egypt, for example. Some cultural factors such as religion, and environmental factors will be different. Several factors have to be taken into account.”

The EAN is also working hard to get global governments to pay attention to brain health. “We went to the G7 last year in Italy; we are going to the G7 in Canada [in June]. We are working with the American Academy, and with the World Neurological Federation, the main international neurological society, to stimulate this area at a political level.”

The message to governments is this, says Moro: “The brain is an investment. You have a treasure, you have to invest in your citizens, and the best way to invest is to preserve their brains, because without the brain, there’s nothing, no economy, nothing.”

The EAN will also spread this message at the EAN Congress in Finland this June. “We have 9,000 people coming, all the neurologists in the societies in Europe. We have several initiatives during the Congress, especially concentrating on the younger generation.”

The EAN, along with partners in the Brain Health Mission, is also working to support the WHO’s 10-year Intersectoral Global Action Plan for Epilepsy and other Neurological Disorders (iGAP), which aims to address the burden of epilepsy and other neurological disorders and improve access to care and treatment for affected individuals, families, and communities worldwide, as well as raise awareness and reduce stigma.

Asked if governments are realising the urgency of the need to improve brain health, Moro says: “I think they’re realising that this is very serious, because the costs [of neurological diseases] are increasing, the number of people living is increasing, and we are not increasing as neurologists. There’s no other solution visible to cope with this neurological pandemic.”

Parkinson’s cases will double to 25 million by 2050, BMJ study says

06 March 2025 Laura Vickers-Green
News

A new modelling study published today in the BMJ (British Medical Journal) suggests there will be 25 million people living with Parkinson’s worldwide by 2050, more than doubling the current global prevalence of Parkinson’s.

Researchers from Capital Medical University in Beijing, China, conducted this latest modelling study using data from the 2021 Global Burden of Disease Study to predict the prevalence of Parkinson’s in 195 countries and territories from 2022 to 2050.

The findings suggest the number of people living with the condition in 2050 will be 25.2 million, a 112% increase compared to 2021.

The study also looked at the the factors driving changes in Parkinson’s cases, concluding this sharp rise will largely be due to an ageing population.

Projected age standardised prevalence (per 100 000) of Parkinson’s disease in 2050, by country and territory for both sexes combined

Which countries will have the most Parkinson’s cases?

Researchers said Parkinson’s will become more common across the world, but countries with poorer socioeconomic status, as well as those with the largest ageing populations, will see the biggest increase in cases. The study also noted that risk factors included environmental agents (like air pollution and pesticides), climate change, unhealthy lifestyle, metabolic diseases, and dietary factors.

East Asia will see the highest number of cases – 10.9 million – with China and Japan most affected, whereas the largest increase in cases will be in western Sub-Saharan Africa, where people are generally living longer than before.

In Europe, cases are expected to rise by 50% in Western Europe, and by 28% in Central and Eastern Europe.

The European countries with the highest prevalence rates won’t differ much to the most-affected countries now – Germany, Italy, France, Spain and the UK – but the numbers of cases will of course see a sharp rise, according to the modelling study.

Germany, for instance, is expected to have 574,000 cases in 2050 (up from 414,000 in the 2021 Global Burden of Disease Study), whereas the UK is expected to have 307,000 cases (vs. 199,000), and France and Spain will both top 350,000 Parkinson’s cases (up from 241,000 and 200,000, respectively).

One European anomaly was Italy: the modelling study predicts the number of Parkinson’s cases will actually fall to 177,000 in 2050, down from 190,000 in 2021.

Estimated top 10 countries with highest number of Parkinson’s disease (PD) cases in 1990, 2021, 2030, 2040, and 2050 globally. Corresponding boxes present number of PD cases in this country and their proportion among global PD patients, as well as global count

What does this study mean?

We already know that Parkinson’s is the fastest-growing neurological condition in the world, and similar predictions about prevalence numbers have been around for a while, but this study is an important reminder that Parkinson’s is growing at an alarming rate, and will also go on to affect some countries’ healthcare systems much more than others.

“By 2050 Parkinson’s disease will have become a greater public health challenge for patients, their families, care givers, communities, and society,” the study authors concluded, adding a suggestion that this study “could serve as an aid in promoting health research, informing policy decisions, and allocating resources.”

This is something our Strategic Director, Amelia Hursey, agrees with. Speaking to EuroNews, Amelia said:

“It just shows that it absolutely needs to be addressed now, because there is no way that any of the global health services can cope with that level of demand from one specific condition.”

Parkinson’s UK Director of Research, David Dexter, added:

“This very welcome study reminds us that Parkinson’s is growing quickly across the world. Until we find a cure, it’s vital that people with Parkinson’s, regardless of their location, socioeconomic group or race, have access to research opportunities, good quality care and support that enables them to live well with the condition.”

Find out more key Parkinson’s statistics.